Index of Slides : Text Mostly Version

1. Results and Impact of Electronic Prescribing (e-Rx) Use; 3rd teleconference in a series of four on the Medicare Modernization Act e-RX Pilot Evaluation November 2, 2007
2. ePrescribing Pilot Findings Ken Majkowski, Pharm D Vice President, Clinical Affairs and Product Strategy November 2, 2007
3. Background
4. RxHub Overview
5. RxHub Success Factors
6. RxHub Services
7. No Title
8. No Title
9. No Title
10. ePrescribing Pilot Participants
11. Outcomes to Discuss
12. Standards
13. Formulary & Benefits Findings
14. RxHub Master Person Index Coverage – October 2007
15. ePrescribing Case Studies
16. Medication History Findings
17. Summary - Med History Focus Group Findings
18. Long Term Care Findings
19. Outcomes
20. Conclusion
21. Conclusion
22. Thank You
23. Studies of E-Prescribing Adoption and Use in the New Jersey E-Prescribing Action Coalition
24. Medicare Modernization Act
25. Conceptual Model
26. New Jersey E-prescribing Action Coalition
27. Methods: Adoption and Use Analysis
28. Enrollment and Activation
29. Factors Associated with Participation
30. E-Prescribing Usage
31. Factors Associated with eRx Use
32. Methods: Qualitative Case Study
33. Case Study Results
34. Unsuccessful site
35. Successful site
36. Shifts in Work
37. Methods: Prescriber Survey
38. Overall Experiences with E-prescribing
39. Conclusions
40. Maximizing the Effectiveness of E-Prescribing Between Physicians and Community Pharmacies: Implementation
41. OVERVIEW
42. Evaluation Strategies:
43. Patient Perspectives
44. Variation in patient preference for e-prescribing
45. Physician comments on patient preference
46. Patients knowledge about e-prescribing
47. Physician comments on consistency of e-rx use
48. Patient expectations of prescription readiness
49. Patient satisfaction with e-prescribing as dispensed at pharmacy
50. Clinician perspectives
51. How use of e-prescribing software has affected job compared to other methods
52. Perceptions on how e-prescribing has impacted quality and safety
53. E-prescribing compared to other methods in terms of communication w/ pharmacies
54. Pharmacy relationship
55. Pharmacy perspective
56. Pharmacist perceptions
57. More work to be done…..
58. Industry perspective: Codified SIG
59. Industry perspective: Codified SIG
60. SUMMARY
61. Summary
62. Bibliography
63. Northeast Ohio CMS eRx Project
64. NEO eRx Project Participants
65. NEO eRx: Workflow Overview
66. No Title
67. No Title
68. Small Practice Adoption: Magic Mix
69. Pre-Project eRx Adoption (All of UHMP)
70. Pre-Project eRx Adoption (by Practice)
71. eRx (Study) and Control Practices
72. eRx and Control Practices
73. e-Prescribing @ 25 UHMP Practices
74. eRx / prescriber / mo (10/06 by practice)
75. Surrogate-Based e-Prescribing
76. Renewal Workflow Findings
77. Characterizing Rx-Related Phone Calls
78. eRx Impact on Call Types
79. NEO eRx: Workflow Overview
80. Eligibility Checking Workflow
81. Jan à Dec ’06: 176K + responses / 300K checks (~59% hit rate)
82. RxHub MPI Coverage in NEO (2006)
83. Eligibility Checking Transactions ‘06
84. Medication History Transfer Workflow
85. Medication History Transfer Workflow
86. June à Sept ’06: 46K med hx transfers (only 500 “views”)
87. Medication History Actual “Views”
88. Prescription Routing Transactions
89. Prescription Routing Workflow
90. NEO eRx: Workflow Overview
91. Medication History (SureScripts)
92. Medication History Test
93. Med History Transfers vs. Views
94. RxFILL / NoFILL
95. RxFill / NoFILL Testing
96. ePrior Auth (X12 278 + 275)
97. Prior Authorization Testing
98. Summary: Adoption and Workflow
99. Summary: Standards

Return to Format List